ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1380

Characterization of Lymphocytes Subsets in Peripheral Blood of Untreated IgG4-Related Disease Patients

Aurélie Grados1, Mikael Ebbo1, Christelle Piperoglou2, Matthieu Groh3, Alexis Regent4, Maxime Samson5, Benjamin Terrier6, Nathalie Morel7, Sylvain Audia5, Francois Maurier8, Julie Graveleau9, Mohamed Hamidou10, Amandine Forestier11, Sylvain Palat12, Emanuelle Bernit1, Gilles Kaplanski13, Frederique Retornaz14, Bernard Bonotte5, Catherine Farnarier15, Jean-Robert Harle16, Nathalie Costedoat-Chalumeau7, Frederic Vely17 and Nicolas Schleinitz1, 1Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, 2Immunology, CIML, AP-HM, Marseille, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 4Service de médecine interne, Hôpital Cochin, Paris, France, 5Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, 6Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France, 7Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 8HP Metz Belle Isle Hospital, Department of Internal Medicine, Metz, France, 9Medecine Interne Hotel Dieu Nantes, Nantes, France, 10Internal Medicine Department, Nantes University Hospital, Nantes, France, 11Internal Medicine, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France, 12Service de Medecine Interne, CHU limoges, Limoges, France, 13Internal Medicine hopital conception, Aix-Marseille Université, Marseille, France, 14Conseil General 13 cellule recherche, Marseille, France, 15Laboratoire d'immunologie, Hopital de la Conception, Marseille, France, 16Internal Medicine, Aix-Marseille Université, APHM, Marseille, France, 17CIML, Laboratoire d'Immunologie Conception AP-HM, Aix-Marseille université, Marseille, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: B cells, IgG4 Related Disease, T cells, T-Regulatory Cells and cytokines

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster Session II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: IgG4-related disease (IgG4-RD) is associated with characteristic pathological changes including lymphoplasmocytic infiltration with abundant IgG4 positive plasma cells, storiform fibrosis and obliterative phlebitis. The etiology of the disease is unknown but a chronic antigen driven process leading to the production of IgG4 and IgG4+ plasmablasts is proposed. Various T cell subsets have been analyzed in the disease however in small studies. Their role remains unclear. We conducted a study to characterize peripheral blood immune cells subsets in patients with untreated IgG4-RD.

Methods:

Thirty patients with IgG4-RD were included prospectively in the study and compared to healthy controls (HC) and primary Sjögren syndrome (pSS) patients. Patients fulfilled the 2011 comprehensive IgG4-RD diagnostic criteria and the 2002 American-European Consensus Group criteria for pSS. PBMC of patients and controls were analyzed by flow cytometry on a BD FACS Canto II. T regulatory cells were characterized as CD4+ FoxP3+ CD25highCD127low, T cells were categorized as memory or naive by CD45RO and CD45RA expression, B cells were categorized as naive or switched memory by IgD and CD27 expression, plasmablasts were characterized as CD19+CD27highCD38high, dendritic cells were categorized as plasmacytoid or myeloid by CD11c and CD123 expression, NK cells were characterized as CD3– CD56+CD16+ .CD4+ T helper subsets were analyzed after stimulation by intracellular staining for IL-4 (Th2), IFNg (Th1) and IL-17 (Th17). The cytokine production for IL-4, IL-10 and IL-17 was performed with the cytokine bead assay (CBA® kit, BD Biosciences) on supernatant of stimulated PBMC. Statistical analysis was performed on PRISM software.

Results:

The frequency and absolute number of total T cells, CD4+ and CD8+T cells, CD45RA and CD45RO, total DC, T regulatory cells, NK cells, B and naive B cells did not show any changes between IgG4-RD patients and HC. pDC were decreased in IgG4-RD compared with HC (p=0.01) and pSS (p=0.01). Plasmablasts frequency (p=0.0003) and absolute numbers (p=0.0004) were increased in IgG4-RD patients when compared to HC. T helper subsets analysis showed an increase of Th2 cells (p=0.0004), Th17 cells (p=0.03) but not Th1 cells when compared to HC. The cytokine production by PBMC showed an increased release of IL-4 (p<0.0001), IL-10 (p=0.004) and IL-17 (p=0.001) by IgG4-RD compared to HC.

Conclusion: Baseline changes of immune cells in peripheral blood of IgG4-RD patients is characterized by plasmablast expansion, as previously reported, a decrease of plasmacytoid DC and a T helper switch to Th2 IL-4 producing cells. We also show an increase in IL-10 release and an increase of both Th17 cells and IL-17 release. Further studies are required to elucidate the role of these different subsets in the pathogenesis of IgG4-RD.


Disclosure: A. Grados, None; M. Ebbo, None; C. Piperoglou, None; M. Groh, None; A. Regent, None; M. Samson, None; B. Terrier, None; N. Morel, None; S. Audia, None; F. Maurier, None; J. Graveleau, None; M. Hamidou, None; A. Forestier, None; S. Palat, None; E. Bernit, None; G. Kaplanski, None; F. Retornaz, None; B. Bonotte, None; C. Farnarier, None; J. R. Harle, None; N. Costedoat-Chalumeau, None; F. Vely, None; N. Schleinitz, CSL behring Company France, 2,Roche France, 2,GlaxoSmithKline france, 2.

To cite this abstract in AMA style:

Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Kaplanski G, Retornaz F, Bonotte B, Farnarier C, Harle JR, Costedoat-Chalumeau N, Vely F, Schleinitz N. Characterization of Lymphocytes Subsets in Peripheral Blood of Untreated IgG4-Related Disease Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/characterization-of-lymphocytes-subsets-in-peripheral-blood-of-untreated-igg4-related-disease-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-lymphocytes-subsets-in-peripheral-blood-of-untreated-igg4-related-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology